RNA with chemotherapeutic base analogues as a dual-functional anti-cancer drug.

Saved in:
Bibliographic Details
Title: RNA with chemotherapeutic base analogues as a dual-functional anti-cancer drug.
Authors: Jarzebska NT; Department of Dermatology, University Hospital Zürich (USZ), University of Zürich (UZH), Raemistrasse 100, 8091, Zürich, Switzerland.; Faculty of Science, University of Zürich, Zürich, Switzerland., Tusup M; Department of Dermatology, University Hospital Zürich (USZ), University of Zürich (UZH), Raemistrasse 100, 8091, Zürich, Switzerland.; Faculty of Medicine, University of Zürich, Zürich, Switzerland., Frei J; Department of Dermatology, University Hospital Zürich (USZ), University of Zürich (UZH), Raemistrasse 100, 8091, Zürich, Switzerland.; Faculty of Medicine, University of Zürich, Zürich, Switzerland., Weiss T; Department of Neurology and Clinical Neuroscience Center, University Hospital Zürich (USZ), University of Zürich (UZH), 8091, Zürich, Switzerland., Holzinger T; Department of Dermatology, University Hospital Zürich (USZ), University of Zürich (UZH), Raemistrasse 100, 8091, Zürich, Switzerland.; Faculty of Medicine, University of Zürich, Zürich, Switzerland., Mellett M; Department of Dermatology, University Hospital Zürich (USZ), University of Zürich (UZH), Raemistrasse 100, 8091, Zürich, Switzerland.; Faculty of Medicine, University of Zürich, Zürich, Switzerland., Diken M; BioNTech SE, Mainz, Germany., Bredl S; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zürich (USZ), University of Zürich (UZH), 8091, Zürich, Switzerland., Weller M; Department of Neurology and Clinical Neuroscience Center, University Hospital Zürich (USZ), University of Zürich (UZH), 8091, Zürich, Switzerland., Speck RF; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zürich (USZ), University of Zürich (UZH), 8091, Zürich, Switzerland., Kündig TM; Department of Dermatology, University Hospital Zürich (USZ), University of Zürich (UZH), Raemistrasse 100, 8091, Zürich, Switzerland.; Faculty of Medicine, University of Zürich, Zürich, Switzerland., Sahin U; BioNTech SE, Mainz, Germany., Pascolo S; Department of Dermatology, University Hospital Zürich (USZ), University of Zürich (UZH), Raemistrasse 100, 8091, Zürich, Switzerland.; Faculty of Medicine, University of Zürich, Zürich, Switzerland.
Source: Oncoimmunology [Oncoimmunology] 2022 Nov 18; Vol. 11 (1), pp. 2147665. Date of Electronic Publication: 2022 Nov 18 (Print Publication: 2022).
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: eCollection Cited Medium: Internet ISSN: 2162-402X (Electronic) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2162-402X
DOI:10.1080/2162402X.2022.2147665